MeiraGTx Reports Wider Q1 Loss; Revenue Improves
09:15 AM EDT, 05/11/2021 (MT Newswires) -- MeiraGTx Holdings (MGTX) on Tuesday reported a Q1 net loss of $0.54 per share, compared with $0.43 loss per share a year ago. Analysts polled by Capital IQ had called for $0.43 loss per share.
Revenue totaled $4.6 million for the March quarter, up from $4.2 million last year. Wall Street was looking for $1.4 million.
The vertically-integrated, clinical-stage gene therapy company said it ended Q1 with $199.4 million of cash and cash equivalents, compared with $209.5 million at the end of Q4.
The company said it believes it will have sufficient capital to fund operating expenses and capital expenditure requirements into mid-2023.
Price: 13.00, Change: -0.50, Percent Change: -3.70